Status:
RECRUITING
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Candida
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the implementation of a new technique for invasive candidiasis diagnosis by PCR. The main objective will be to evaluate the effect of this strategy on the time req...
Detailed Description
Invasive candidiasis is a serious infection caused by yeasts of the genus Candida sp. Their incidence is increasing, particularly in intensive care. The prognosis is severe and depends on the early in...
Eligibility Criteria
Inclusion
- Patient affiliated or benefiting from a social protection system
- Patient (or his/her trusted person) having given free and informed written consent to the investigating physician
- Non-neutropenic patient hospitalised in the Toulouse University Hospital intensive care unit.
- Patient with suspected invasive candidiasis for whom a blood culture for fungal infection diagnosis was taken and for whom an empirical treatment with echinocandin at an adapted dose was implemented.
Exclusion
- Patients under guardianship or trusteeship, persons under court protection
- Pregnant or breastfeeding patients.
Key Trial Info
Start Date :
May 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04874441
Start Date
May 19 2022
End Date
August 1 2025
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Toulouse
Toulouse, Occitanie, France, 31000